216 related articles for article (PubMed ID: 14651332)
21. Heparin and low-molecular-weight heparin therapy for venous thromboembolism: will unfractionated heparin survive?
Hull RD; Pineo GF
Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():11-23. PubMed ID: 15085462
[TBL] [Abstract][Full Text] [Related]
22. Treatment of thromboembolism in cancer patients.
Panova-Noeva M; Falanga A
Expert Opin Pharmacother; 2010 Aug; 11(12):2049-58. PubMed ID: 20642371
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis and initial treatment of venous thromboembolism in patients with cancer.
Streiff MB
J Clin Oncol; 2009 Oct; 27(29):4889-94. PubMed ID: 19738109
[TBL] [Abstract][Full Text] [Related]
24. Warfarin versus low-molecular-weight heparin therapy in cancer patients.
Zacharski LR; Prandoni P; Monreal M
Oncologist; 2005 Jan; 10(1):72-9. PubMed ID: 15632254
[TBL] [Abstract][Full Text] [Related]
25. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival.
Alcalay A; Wun T; Khatri V; Chew HK; Harvey D; Zhou H; White RH
J Clin Oncol; 2006 Mar; 24(7):1112-8. PubMed ID: 16505431
[TBL] [Abstract][Full Text] [Related]
26. Age, cancer and the risk of venous thromboembolism.
Fimognari FL; Repetto L; Moro L; Gianni W; Incalzi RA
Crit Rev Oncol Hematol; 2005 Sep; 55(3):207-12. PubMed ID: 15979886
[TBL] [Abstract][Full Text] [Related]
27. Blood coagulation and cancer: thrombosis and survival, clinical relevance and impact. An introduction.
Vestjens JH; Sassen S; Prins MH
Pathophysiol Haemost Thromb; 2008; 36(3-4):113-21. PubMed ID: 19176984
[TBL] [Abstract][Full Text] [Related]
28. Venous thromboembolism: risk factors for recurrence.
Zhu T; Martinez I; Emmerich J
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
[TBL] [Abstract][Full Text] [Related]
29. Cancer, thrombosis and heparin-induced thrombocytopenia.
Prandoni P; Falanga A; Piccioli A
Thromb Res; 2007; 120 Suppl 2():S137-40. PubMed ID: 18023709
[TBL] [Abstract][Full Text] [Related]
30. Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experience.
Vemulapalli S; Chintala L; Tsimberidou AM; Dhillon N; Lei X; Hong D; Kurzrock R
Am J Hematol; 2009 Jul; 84(7):408-13. PubMed ID: 19437507
[TBL] [Abstract][Full Text] [Related]
31. Prophylaxis against venous thromboembolism in acutely ill medical patients: an observational study.
Peterman CM; Kolansky DM; Spinler SA
Pharmacotherapy; 2006 Aug; 26(8):1086-90. PubMed ID: 16863485
[TBL] [Abstract][Full Text] [Related]
32. New antithrombotic drugs: potential for use in oncology.
Levine MN
J Clin Oncol; 2009 Oct; 27(29):4912-8. PubMed ID: 19738103
[TBL] [Abstract][Full Text] [Related]
33. Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates.
Stinnett JM; Pendleton R; Skordos L; Wheeler M; Rodgers GM
Am J Hematol; 2005 Mar; 78(3):167-72. PubMed ID: 15726600
[TBL] [Abstract][Full Text] [Related]
34. Cancer-associated thrombosis: focus on extended therapy with dalteparin.
Bick RL
J Support Oncol; 2006 Mar; 4(3):115-20. PubMed ID: 16553136
[TBL] [Abstract][Full Text] [Related]
35. Clinically overt venous thromboembolism after urologic cancer surgery: results from the @RISTOS Study.
Scarpa RM; Carrieri G; Gussoni G; Tubaro A; Conti G; Pagliarulo V; Mirone V; De Lisa A; Fiaccavento G; Cormio L; Bonizzoni E; Agnelli G;
Eur Urol; 2007 Jan; 51(1):130-5; discussion 136. PubMed ID: 16942832
[TBL] [Abstract][Full Text] [Related]
36. Prognosis of ovarian cancer subsequent to venous thromboembolism: a nationwide Danish cohort study.
Tetsche MS; Nørgaard M; Pedersen L; Lash TL; Sørensen HT
BMC Cancer; 2006 Jul; 6():189. PubMed ID: 16846496
[TBL] [Abstract][Full Text] [Related]
37. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
38. Treatment of venous thromboembolism in cancer patients.
Lee AY
Best Pract Res Clin Haematol; 2009 Mar; 22(1):93-101. PubMed ID: 19285276
[TBL] [Abstract][Full Text] [Related]
39. Cancer and venous thromboembolism. Clinical implications of strong association.
Prandoni P
Pathophysiol Haemost Thromb; 2006; 35(1-2):111-5. PubMed ID: 16855355
[TBL] [Abstract][Full Text] [Related]
40. Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: a review of current guidelines.
Petersen LJ
Cancer Treat Rev; 2009 Dec; 35(8):754-64. PubMed ID: 19762155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
